VIKTORIYA FRIDMAN: Open Payments
NPI 1033434477 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,588 in 122 payments from 20 companies in 2025. Trend: 2023 $456 · 2024 $1,096 · 2025 $6,588
Food & beverage: $4,978Consulting: $1,600Education: $10
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 16 | $2,330 |
| Incyte Corporation | 22 | $979 |
| ABBVIE INC. | 9 | $517 |
| GENZYME CORPORATION | 9 | $480 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $430 |
| Galderma Laboratories, L.P. | 4 | $354 |
| LEO Pharma Inc. | 5 | $333 |
| Regeneron Healthcare Solutions, Inc. | 5 | $243 |
| Amgen Inc. | 9 | $204 |
| Organon LLC | 4 | $157 |
Products named: OPZELURA, DUPIXENT, Zoryve, ANZUPGO, ILUMYA, NEMLUVIO, SKYRIZI, OTEZLA.
Industry payments across NY — which companies pay providers there.
